FIELD: chemistry.
SUBSTANCE: invention pertains to a polymorphous modification of A N-benzyl- N'-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide, which is characterised by X-ray powder diffraction pattern with characteristic peaks at approximately 16.0, 19.6 and 28.1 for 2θ degrees.
EFFECT: obtaining a composition which can be used to make a medicinal agent for reducing secretion of sebum and treating skin disorders.
6 cl, 4 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS CONTAINING MALONAMIDE DERIVATIVES FOR DECREASE OF PRODUCTION OF SKIN FAT | 2004 |
|
RU2342930C2 |
| POLYMORPHIC MODIFICATIONS OF N-[(3-FLUORO-4-METHOXYPYRIDINE-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({ 4-[(2-OXOPYRIDINE-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AND THEIR SALTS | 2017 |
|
RU2756273C2 |
| C-MET/HGFR INHIBITOR POLYMORPHS | 2006 |
|
RU2387650C2 |
| METHODS OF PRODUCTION ISOQUINOLINONES AND SOLID FORMS ISOQUINOLINONES | 2012 |
|
RU2626883C2 |
| MENIN-MLL INTERACTION INHIBITORS | 2017 |
|
RU2799820C2 |
| CRYSTAL FORMS OF IMIDAZOLE DERIVATIVE | 2006 |
|
RU2357968C1 |
| CRYSTALLINE FORMS OF MONOSODIUM SALT OF D-ISOGLUTAMYL-D-TRYPTOPHAN | 2008 |
|
RU2476440C2 |
| C-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN CANCER TREATMENT | 2018 |
|
RU2769694C2 |
| NOVEL CRYSTALLINE FORMS OF ROSIGLYTASONE, METHODS OF THEIR OBTAINING, PHARMACEUTICAL COMPOSITION AND BASED ON THEM METHOD OF TREATMENT | 2004 |
|
RU2342385C2 |
| TOPOTECAN MONOHYDROCHLORIDE PENTAHYDRATE IN CRYSTALLINE FORM, CORRESPONDING COMPOSITIONS BASED ON THEM, PREPARATION AND/OR TREATMENT METHODS | 2004 |
|
RU2352572C2 |
